Trial intelligence / Profile preview

PREFLUCEL effectiveness against seasonal influenza infection

2011-003106-24Phase 4Terminated

Sponsor
Baxter International Inc.
Start
Aug 2011
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of cell culture-derived trivalent subunit influenza vaccine in seasonal influenza, sponsored by Baxter International Inc. Started Aug 2011; status: terminated.

02

Drugs

cell culture-derived trivalent subunit influenza vaccine
03

Conditions

seasonal influenza

Beyond the preview

Go deeper on 2011-003106-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003106-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call